Literature DB >> 23255904

Expression pattern of polypeptide N-acetylgalactosaminyltransferase-10 in gastric carcinoma.

Yuan Gao1, Zhenhua Liu, Jinghua Feng, Qizhe Sun, Bao Zhang, Wenling Zheng, Wenli Ma.   

Abstract

The aim of this study was to detect the expression of the pp GalNac-T10 protein in gastric carcinoma and to investigate the role of pp GalNac-T10 in the occurrence and development of gastric cancer tissues. pp GalNac-T10 protein expression was immunohistochemically analyzed in 96 gastric adenocarcinoma tissue samples, and in 88 5-cm adjacent non-tumor gastric mucosa samples, used as controls. pp GalNAc-T10 expression in gastric cancer tissues was higher compared with that in the adjacent non-tumor gastric tissue. pp GalNAc-T10 protein expression had a significant positive correlation with histological type and degree of differentiation of gastric cancer (P<0.05). Expression in diffuse type gastric cancer was notably higher compared with that in intestinal type gastric cancer. Expression in poorly differentiated tumors was markedly higher compared with that in high and mid degree differentiated tumors. pp GalNAc-T10 protein expression was not significantly positively correlated with clinical stage, depth of invasion or lymph node metastasis (P>0.05). pp GalNAc-T10 expression is a useful indicator of tumor differentiation in gastric cancer.

Entities:  

Year:  2012        PMID: 23255904      PMCID: PMC3525504          DOI: 10.3892/ol.2012.980

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  10 in total

1.  Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T10.

Authors:  Lamei Cheng; Kouichi Tachibana; Yan Zhang; Jian ming Guo; Kahori Kahori Tachibana; Akihiko Kameyama; Han Wang; Toru Hiruma; Hiroko Iwasaki; Akira Togayachi; Takashi Kudo; Hisashi Narimatsu
Journal:  FEBS Lett       Date:  2002-11-06       Impact factor: 4.124

Review 2.  Pathways of O-glycan biosynthesis in cancer cells.

Authors:  I Brockhausen
Journal:  Biochim Biophys Acta       Date:  1999-12-06

3.  Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells.

Authors:  S Ehata; E Johansson; R Katayama; S Koike; A Watanabe; Y Hoshino; Y Katsuno; A Komuro; D Koinuma; M R Kano; M Yashiro; K Hirakawa; H Aburatani; N Fujita; K Miyazono
Journal:  Oncogene       Date:  2010-12-06       Impact factor: 9.867

4.  regulation of the invasion and metastasis of human glioma cells by polypeptide N-acetylgalactosaminyltransferase 2.

Authors:  Jun Liu; Lingyan Yang; Meifang Jin; Lan Xu; Shiliang Wu
Journal:  Mol Med Rep       Date:  2011-08-22       Impact factor: 2.952

5.  UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.

Authors:  Nora Berois; Daniel Mazal; Luis Ubillos; Felipe Trajtenberg; André Nicolas; Xavier Sastre-Garau; Henri Magdelenat; Eduardo Osinaga
Journal:  J Histochem Cytochem       Date:  2005-10-31       Impact factor: 2.479

6.  N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.

Authors:  Chen Wu; Xiaodan Guo; Weina Wang; Yun Wang; Yaojun Shan; Bo Zhang; Wenqian Song; Sisi Ma; Jianfeng Ge; Hao Deng; Mingsheng Zhu
Journal:  BMC Cancer       Date:  2010-04-01       Impact factor: 4.430

7.  Regulation of TGF-(beta) signalling by N-acetylgalactosaminyltransferase-like 1.

Authors:  Patrick Herr; Ganna Korniychuk; Yukiyo Yamamoto; Kristina Grubisic; Michael Oelgeschläger
Journal:  Development       Date:  2008-04-16       Impact factor: 6.868

8.  The expression pattern of UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 in early gastric carcinoma.

Authors:  Makoto Ishikawa; Joji Kitayama; Hiroshi Nariko; Kimitoshi Kohno; Hirokazu Nagawa
Journal:  J Surg Oncol       Date:  2004-04-01       Impact factor: 3.454

9.  Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.

Authors:  Akiyoshi Komuro; Masakazu Yashiro; Caname Iwata; Yasuyuki Morishita; Erik Johansson; Yoshiko Matsumoto; Akira Watanabe; Hiroyuki Aburatani; Hiroyuki Miyoshi; Kunihiko Kiyono; Yo-taro Shirai; Hiroshi I Suzuki; Kosei Hirakawa; Mitsunobu R Kano; Kohei Miyazono
Journal:  J Natl Cancer Inst       Date:  2009-04-07       Impact factor: 13.506

10.  Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence.

Authors:  C Gu; T Oyama; T Osaki; J Li; M Takenoyama; H Izumi; K Sugio; K Kohno; K Yasumoto
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

  10 in total
  8 in total

1.  Development of isoform-specific sensors of polypeptide GalNAc-transferase activity.

Authors:  Lina Song; 丽娜 宋; Collin Bachert; Katrine T Schjoldager; Henrik Clausen; Adam D Linstedt
Journal:  J Biol Chem       Date:  2014-09-15       Impact factor: 5.157

2.  Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.

Authors:  Zhi-Qiang Wang; Magdalena Bachvarova; Chantale Morin; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Dimcho Bachvarov
Journal:  Oncotarget       Date:  2014-01-30

3.  Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer.

Authors:  H He; Z Shen; H Zhang; X Wang; Z Tang; J Xu; Y Sun
Journal:  Br J Cancer       Date:  2014-03-11       Impact factor: 7.640

Review 4.  Mucin-Type O-Glycosylation in Gastric Carcinogenesis.

Authors:  Henrique O Duarte; Daniela Freitas; Catarina Gomes; Joana Gomes; Ana Magalhães; Celso A Reis
Journal:  Biomolecules       Date:  2016-07-11

5.  Inhibitor of ppGalNAc-T3-mediated O-glycosylation blocks cancer cell invasiveness and lowers FGF23 levels.

Authors:  Lina Song; Adam D Linstedt
Journal:  Elife       Date:  2017-03-31       Impact factor: 8.140

6.  Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation.

Authors:  Shin-Yun Liu; Chia-Tung Shun; Kuan-Yu Hung; Hsueh-Fen Juan; Chia-Lang Hsu; Min-Chuan Huang; I-Rue Lai
Journal:  Oncotarget       Date:  2016-03-08

7.  GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway.

Authors:  Yingge Mao; Yuqi Zhang; Sairong Fan; Lvao Chen; Lili Tang; Xiaoming Chen; Jianxin Lyu
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

Review 8.  MUC1 is an oncoprotein with a significant role in apoptosis (Review).

Authors:  Katarzyna Supruniuk; Iwona Radziejewska
Journal:  Int J Oncol       Date:  2021-07-19       Impact factor: 5.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.